Doctors test gene injection to heal damaged hearts during surgery
NCT ID NCT01422772
Summary
This early-stage study tested the safety of a new gene therapy called VM202 (Engensis). It was injected directly into the heart muscle of nine patients during their coronary artery bypass surgery, specifically in areas that could not be fully repaired by the surgery itself. The main goal was to see if the injections were safe and to find a tolerable dose, while also checking for any early signs that it might help improve heart function.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ISCHEMIC HEART DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Seoul National University Hospital
Seoul, South Korea
Conditions
Explore the condition pages connected to this study.